Company Filing History:
7 out of 344 
1 out of 1,217 
1 out of 2,202 
Years Active: 1995-2019
Title: Esther Priel: Innovator in Telomerase Activation and Diabetes Treatment
Introduction
Esther Priel is a prominent inventor based in Beer Sheva, Israel, known for her significant contributions to the fields of biotechnology and medicine. With a total of nine patents to her name, she has made remarkable strides in developing innovative solutions for health-related issues.
Latest Patents
Among her latest patents, one focuses on "Telomerase activating compounds and methods of use thereof." This invention is directed towards utilizing a series of compounds and compositions to activate telomerase, which can aid in treating various diseases, disorders, and conditions associated with telomere shortening. Another notable patent involves "Compounds for the treatment of diabetes and disease complications arising from same." This invention highlights the use of tri-aryl compounds for treating diabetes and the complications that may arise from the condition.
Career Highlights
Esther has worked with esteemed institutions, including the Ben-Gurion University of the Negev Research and Development Authority. Her work has significantly impacted the research community, particularly in the areas of telomerase activation and diabetes treatment.
Collaborations
Esther has collaborated with notable colleagues such as Aviv Gazit and Shimon Slavin, contributing to the advancement of her research and innovations.
Conclusion
Esther Priel's work exemplifies the spirit of innovation in the medical field, particularly in addressing critical health challenges through her patented inventions. Her contributions continue to pave the way for future advancements in biotechnology and medicine.